Bcl-2 phosphorylation is required for inhibition of oxidative stress-induced lysosomal leak and ensuing apoptosis

被引:57
作者
Zhao, M [1 ]
Eaton, JW
Brunk, UT
机构
[1] Linkoping Univ, Fac Hlth Sci, Div Pathol 2, SE-58185 Linkoping, Sweden
[2] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA
关键词
apoptosis; B-cell leukemia/lymphoma 2; lysosome stability; oxidative stress; protein kinase C;
D O I
10.1016/S0014-5793(01)03185-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
B-cell leukemia/lymphoma 2 (Bcl-2) blocks oxidant-induced apoptosis at least partly by stabilizing lysosomes. Here we report that phosphorylation of Bcl-2 may be required for these protective effects. J774 cells overexpressing wild-type Bcl-2 resist oxidant-induced lysosomal leak as well as apoptosis, and this protection is amplified by pretreatment with phorbol 12-myristate 13-acetate (which promotes protein kinase C (PKC)-dependent phosphorylation of Bcl-2). In contrast, cells overexpressing the Bcl-2 mutant S70A (which cannot be phosphorylated) are not protected in either circumstance. Transfection with Bcl-2(S70E), a constitutively active Bcl-2 mutant which does not require phosphorylation, is protective independent of PKC activation. In contrast, C-2-ceramide, a putative protein phosphatase 2A activator, abolishes the protective effects of wild-type Bcl-2 overexpression but does not diminish protection afforded by Bcl-2(S70E). Additional results suggest that, perhaps as a consequence of lysosomal stabilization, Bcl-2 may prevent activation of phospholipase A2, an event potentially important in the ultimate initiation of apoptosis. (C) 2001 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:405 / 412
页数:8
相关论文
共 46 条
[21]   Mitochondrial control of cell death [J].
Kroemer, G ;
Reed, JC .
NATURE MEDICINE, 2000, 6 (05) :513-519
[22]   EVIDENCE THAT DESFERRIOXAMINE CANNOT ENTER CELLS BY PASSIVE DIFFUSION [J].
LLOYD, JB ;
CABLE, H ;
RICEEVANS, C .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (09) :1361-1363
[23]   Induction of cancer cell apoptosis by α-tocopheryl succinate:: molecular pathways and structural requirements [J].
Neuzil, J ;
Weber, T ;
Schröder, A ;
Lu, M ;
Ostermann, G ;
Gellert, N ;
Mayne, GC ;
Olejnicka, B ;
Nègre-Salvayre, A ;
Stícha, M ;
Coffey, RJ ;
Weber, C .
FASEB JOURNAL, 2001, 15 (02) :403-415
[24]   A RAPID AND SIMPLE METHOD FOR MEASURING THYMOCYTE APOPTOSIS BY PROPIDIUM IODIDE STAINING AND FLOW-CYTOMETRY [J].
NICOLETTI, I ;
MIGLIORATI, G ;
PAGLIACCI, MC ;
GRIGNANI, F ;
RICCARDI, C .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 139 (02) :271-279
[25]   Lysosomal heterogeneity between and within cells with respect to resistance against oxidative stress [J].
Nilsson, E ;
Ghassemifar, R ;
Brunk, UT .
HISTOCHEMICAL JOURNAL, 1997, 29 (11-12) :857-865
[26]  
Nitatori T, 1996, ADV EXP MED BIOL, V389, P177
[27]   A short exposure to a high-glucose milieu stabilizes the acidic vacuolar apparatus of insulinoma cells in culture to ensuing oxidative stress [J].
Olejnicka, BT ;
Ollinger, K ;
Brunk, UT .
APMIS, 1997, 105 (09) :689-698
[28]  
OLLINGER K, 1995, FREE RADICAL BIO MED, V19, P565, DOI 10.1016/0891-5849(95)00062-3
[29]   Role of Bcl-2 and its post-transcriptional modification in response to antitumor therapy [J].
Pratesi, G ;
Perego, P ;
Zunino, F .
BIOCHEMICAL PHARMACOLOGY, 2001, 61 (04) :381-386
[30]   Bcl-2 phosphorylation in a human breast carcinoma xenograft: A common event in response to effective DNA-damaging drugs [J].
Pratesi, G ;
Polizzi, D ;
Perego, P ;
Dal Bo, L ;
Zunino, F .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (01) :77-82